Trial intelligence / Profile preview

Early oral magnesium sulfate catharsis for moderate to severe acute pancreatitis (historical controlled study)

ChiCTR2300074044Phase 4Recruiting

Sponsor
Second Affiliated Hospital of Soochow University, Department of Gastroenterology
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of magnesium sulfate in acute pancreatitis (AP) (2 arms), sponsored by Second Affiliated Hospital of Soochow University, Department of Gastroenterology. Primary endpoints: Length of hospital stay, Severity of acute pancreatitis and 2 more. Started Jul 2023; status: recruiting.

02

Drugs

magnesium sulfate
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on ChiCTR2300074044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300074044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call